Mochida Pharmaceutical Co., Ltd. (TYO:4534)
Japan · Delayed Price · Currency is JPY 3,105.00
-75.00 (-2.36%)
Aug 4, 2026, 10:00 AM JST
Mochida Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 116,951 | 116,951 | 105,159 | 102,885 | 103,261 | 110,179 |
Revenue Growth | 11.21% | 11.21% | 2.21% | -0.36% | -6.28% | 6.98% |
Gross Profit Gross Profit Growth | 56,261 | 56,261 | 53,788 | 52,070 | 55,115 | 59,553 |
Operating Income Operating Income Growth | 10,148 | 10,148 | 8,127 | 5,803 | 8,508 | 14,392 |
Net Income Net Income Growth | 7,903 | 7,903 | 5,685 | 4,547 | 6,649 | 10,569 |
Earnings Per Share EPS Growth | 222.93 | 222.93 | 160.36 | 126.79 | 178.93 | 277.39 |
EPS Growth | 39.02% | 39.02% | 26.48% | -29.14% | -35.49% | 24.80% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceutical Pharmaceutical Growth | 109,042 | 109,042 | 97,989 | 96,455 | 97,340 | 104,447 |
Healthcare Business Healthcare Business Growth | 7,908 | 7,908 | 7,169 | 6,430 | 5,920 | 5,732 |
Total Total Growth | 116,950 | 116,950 | 105,158 | 102,885 | 103,260 | 110,179 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 31,057 | 31,057 | 51,150 | 46,789 | 60,509 | 61,914 |
Total Debt Total Debt Growth | 10,000 | 10,000 | - | - | - | - |
Net Cash (Debt) Net Cash Growth | 21,057 | 21,057 | 51,150 | 46,789 | 60,509 | 61,914 |
Net Cash Growth | -58.83% | -58.83% | 9.32% | -22.67% | -2.27% | -2.48% |
Net Cash Per Share Net Cash Per Share Growth | 593.99 | 593.99 | 1442.84 | 1304.66 | 1628.34 | 1624.95 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -7,350 | -7,350 | 9,354 | -7,480 | 7,297 | 7,459 |
Capital Expenditures CapEx Growth | -2,695 | -2,695 | -2,160 | -2,296 | -2,166 | -2,988 |
Free Cash Flow Free Cash Flow Growth | -10,045 | -10,045 | 7,194 | -9,776 | 5,131 | 4,471 |
Free Cash Flow Growth | - | - | - | - | 14.76% | -38.44% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 48.11% | 48.11% | 51.15% | 50.61% | 53.37% | 54.05% |
Operating Margin | 8.68% | 8.68% | 7.73% | 5.64% | 8.24% | 13.06% |
Pretax Margin | 9.55% | 9.55% | 7.66% | 5.99% | 8.76% | 13.24% |
Profit Margin | 6.76% | 6.76% | 5.41% | 4.42% | 6.44% | 9.59% |
FCF Margin | -8.59% | -8.59% | 6.84% | -9.50% | 4.97% | 4.06% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 85.000 | 80.000 | 80.000 | 80.000 | 80.000 | 90.000 |
Dividend Per Share Growth | 3.13% | 0% | 0% | 0% | -11.11% | 0% |
Dividend Yield | 2.72% | 2.31% | 2.57% | 2.60% | 2.57% | 2.65% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.26 | 15.52 | 19.83 | 25.13 | 17.58 | 13.38 |
Forward PE | - | 18.59 | 18.59 | 20.70 | 18.73 | 15.31 |
P/FCF Ratio | - | - | 15.67 | - | 22.78 | 31.64 |
PS Ratio | 0.96 | 1.05 | 1.07 | 1.11 | 1.13 | 1.28 |